![68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study | Journal of Nuclear Medicine 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/58/10/1617/F2.large.jpg)
68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study | Journal of Nuclear Medicine
![Clinical research for PET imaging for prostate cancer begins at Osaka University Hospital | Graduate School of Medicine / Faculty of Medicine, Osaka University Clinical research for PET imaging for prostate cancer begins at Osaka University Hospital | Graduate School of Medicine / Faculty of Medicine, Osaka University](http://www.med.osaka-u.ac.jp/eng/wp-content/uploads/2019/11/9f548ec9f3f8adf07cab62806883bb1b-400x306-400x306.jpg)
Clinical research for PET imaging for prostate cancer begins at Osaka University Hospital | Graduate School of Medicine / Faculty of Medicine, Osaka University
![Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - Practical Radiation Oncology Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - Practical Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2118910396/2086592317/gr1.jpg)
Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - Practical Radiation Oncology
![JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study](https://www.mdpi.com/jcm/jcm-09-02308/article_deploy/html/images/jcm-09-02308-g001.png)
JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
![An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/2/202/F3.large.jpg)
An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine
![SciELO - Brasil - Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases? Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate SciELO - Brasil - Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases? Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate](https://minio.scielo.br/documentstore/1677-6119/LgmKjvPbBJmWzGMgST5cfhx/56a700fad84c55bab5e6e8c824513392a14c47e6.jpg)
SciELO - Brasil - Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases? Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate
![Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy - Urology Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8c9f048a-5962-4409-a239-dc614253c81a/gr1.jpg)
Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy - Urology
![NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA](https://www.iaea.org/sites/default/files/crp-prostate1140x640.jpg)
NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA
![PSMA PET/CT visualises prostate cancer recurrence early, impacts radiation therapy - Med Brief Namibia PSMA PET/CT visualises prostate cancer recurrence early, impacts radiation therapy - Med Brief Namibia](https://www.medbriefnamibia.com/wp-content/uploads/2018/06/figure_1517429862120_2.png)
PSMA PET/CT visualises prostate cancer recurrence early, impacts radiation therapy - Med Brief Namibia
![68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram 68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram](https://www.researchgate.net/profile/Jeremie-Calais/publication/322258012/figure/fig2/AS:611053327118336@1522697874735/68-Ga-PSMA-PET-CT-identified-solitary-L5-metastasis-in-patient-with-recurrent-prostate.png)
68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram
![Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07192-7/MediaObjects/12885_2020_7192_Fig2_HTML.png)
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text
![18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer - Clinical Genitourinary Cancer 18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/05783201-f4f1-45d1-823b-3c36eecef53e/gr1_lrg.jpg)